IceCure Medical Ltd. Ordinary Shares — 四半期決算報告書 (NASDAQ:ICCM) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

Market Capitalization 26.32 M
Employee 66
Founded N/A
CEO Eyal Shamir
Website www.icecure-medical.com
Headquarter Israel
FIGI UNKNOWN
Industry Technology

総売上高

当期純利益

有利子負債合計

フリーキャッシュフロー

現金および現金同等物

26.32 M 時価総額

ニュース

IceCure Medical Ltd (ICCM) Q4 2025 Earnings Call Transcript

アイスキュア・メディカル、2026年1月に臨時株主総会を開催予定

IceCure Medical schedules special shareholder meeting for January 2026

Nvidia, Target, TJX, and more set to report earnings Wednesday

Viatris (VTRS) Beats Q3 Earnings and Revenue Estimates

Acadia Healthcare (ACHC) Beats Q3 Earnings and Revenue Estimates

アイスキュア・メディカル社の株価、凍結療法の研究で生存率向上を受け上昇

IceCure Medical stock jumps after cryoablation study shows improved survival rates

Freezing Cancer With IceCure: ProSense Cryoablation System Receives FDA Marketing Authorization For Early-Stage Breast Cancer Treatment - Icecure Medical (NASDAQ:ICCM)

H.C. ワインライトがIceCure Medicalの目標株価を2.00ドルから2.50ドルに引き上げ

IceCure Medical stock price target raised to $2.50 from $2.00 at H.C. Wainwright

IceCure Medical Ltd (ICCM) U.S. FD&A's MarketingAuthorizationforProSenseCryoablation Call